USPTO grants new CRISPR-Cas9 patent to University of California
The US Patent and Trademark Office (USPTO) has granted a new CRISPR-Cas9 patent to the University of California (UC), the University of Vienna and Emmanuelle Charpentier, marking the fifth consecutive week that the USPTO has approved a new patent in their CRISPR portfolio.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
2 January 2020 The US Patent and Trademark Office has granted the University of California its 20th US patent on CRISPR-Cas9 gene-editing technologies.
1 October 2019 As all sides prepare for a milestone case in the battle over rights to CRISPR/Cas9, LSIPR’s Rory O’Neill finds the CEO of ERS Genomics in a positive mood.
27 June 2019 The US Patent and Trademark Office has revived the dispute between the Broad Institute of MIT and Harvard and the University of California, Berkeley over which first invented the CRISPR gene-editing technology.